Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians' Desk Reference

Archives of Internal Medicine

Volumn 161, Issue 6, 2001, Pages 880-885

  Cohen, J S ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; METOPROLOL; PROPRANOLOL DERIVATIVE; RAMIPRIL;

ARTICLE; BLOOD PRESSURE MONITORING; DOSE RESPONSE; EARLY DIAGNOSIS; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; INFORMATION PROCESSING; LETHARGY; MAJOR CLINICAL STUDY; MEDICAL CARE; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SYNCOPE;

EID: 0035953162     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.6.880     Document Type: Article

References (45)

1. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2. Unfavorable trends in the detection and treatment of hypertension: The Minnesota Heart Survey
3. Stroke prevention: Assessment of risk in a community: The SPARC Study, I: Blood pressure trends, treatment, and control
4. Prevalence of hypertension in the US adult population: Results from the third National Health and Nutrition Examination Survey, 1988-1991
5. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: Data from the health examination surveys, 1960 to 1991
6. Compliance in the treatment of hypertension: A need for action
7. Adherence to pharmacologic management of hypertension
8. Antihypertensive drug therapy the effect of JNC criteria on prescribing patterns and patient status through the first year
9. Optimal dosage of ACE inhibitors in older patients
10. Benefits of adherence to anti-hypertensive drug therapy
11. Persistence with treatment for hypertension in actual practice
12. Low dose combination antihypertensive therapy: Additional efficacy without additional adverse effects?
13. Amlodipine: A double-blind evaluation of the dose-response relationship in mild to moderate hypertension
14. The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: The Quinapril Titration Interval Management Evaluation (ATIME) Study
15. Doctors, nurses, pharmacists and patients: The Rational Evaluation and Choice in Hypertension (REACH) survey of hypertension care delivery
16. The Physicians' Desk Reference: Problems and possible improvements
17. Knowledge resource preferences of family physicians
18. The information needs of family physicians: Case-specific clinical questions
19. 34th Annual top 200 drug issue
20. Hypotensive agents
21. Turning up the heat on hypertension: It's time to be more aggressive in finding and treating this silent killer
22. Matching the treatment to the patient in hypertension
23. Lifestyle intervention: Results of the Treatment of Mild Hypertension Study (TOMHS)
24. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)
25. Non-pharmacological methods reduce drug use in the treatment of hypertension: A two-year trial in general practice
26. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies
27. Hypotensive drugs and first-dose syndrome: Considerations on 6 cases observed during treatment with ACE inhibitors
28. Unexpected first dose hypotensive reaction to enalapril
29. Prolonged hypotension after the first dose of atenolol
30. Hypertension in the elderly
31. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: Results from a population-based study in the elderly
32. Hypertension in women and the elderly: Some puzzling and some expected findings of treatment studies
33. Management of drug therapy in the elderly
34. Medications and older adults
35. Adverse drug reactions: An overview of special considerations in the management of the elderly patient
36. Age- and gender-related use of lowdose drug therapy: The need to manufacture low-dose therapy and evaluate the minimum effective dose
37. Guidelines for the treatment of hypertension: An American view: Fifth Joint National Committee
38. Current trends in the treatment of hypertension a mixed picture
39. Continuing advances in hypertension: The Joint National Committee's fifth report
40. Evaluating drugs after their approval for clinical use
41. Trends in antihypertensive drug use in the United States do the JNC V recommendations affect prescribing?
42. JNC guidelines: Is the message getting through?